Key Points
- Moderna's mRNA technology allows scientists to write and deliver instructions to cells to produce disease-reducing properties
- Having proved itself against Covid, the company is developing multiple mRNA medicines for cancer, flu, Zika and HIV
- Having so many programmes means they don’t all have to succeed for the company to thrive